Siemens Healthineers stock trades at EUR 37.86 as outlook shifts

Published on 10/04/2026 at 14:06 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Siemens Healthineers stock reflects Q3 revenue of EUR 5.764 billion and adjusted EBIT of EUR 1.101 billion. Fiscal 2026 guidance now spans 3.5%-4% growth.

Aquarellbild einer Stadtskyline mit Bürotürmen und Fluss in Pastelltönen — Siemens Healthineers DE000SHL1006 präsentiert Aquarellmalerei einer deutschen Stadtskyline mit modernen Glas-Bürogebäuden am Fluss, Illustration mit AI erstellt.

Siemens Healthineers stock traded at EUR 37.86 on Xetra on October 2, 2026, at 5:39 p.m. CEST, up 0.66 percent on the session. The company had just reported fiscal Q3 revenue of EUR 5.764 billion and adjusted EBIT of EUR 1.101 billion, according to VCBeat Health.

Revenue guidance moves lower

Siemens Healthineers reduced its fiscal 2026 revenue growth outlook from 4.5%-5% to 3.5%-4% after continued weakness in Diagnostics, especially in China. At the same time, the company raised its adjusted EPS guidance to EUR 2.35-2.45 from the earlier range by EUR 0.15, as Yahoo Finance reported from the July 31, 2026 earnings call.

The operating contrast matters. Q3 net profit reached EUR 676 million, up 21.7 percent from EUR 556 million in the comparable quarter, while adjusted EBIT increased 15.6 percent from EUR 953 million, based on the same VCBeat Health report. The stronger earnings line therefore came alongside a weaker top-line outlook rather than a broad-based revenue acceleration.

Diagnostics remains the pressure point

Management attributed the revenue reset to structural market rebasing in China and declining sales from legacy platforms. The earnings guidance increase was tied to tariff refunds, while the underlying EPS range remained unchanged, according to Yahoo Finance.

Consensus targets EUR 45.52

The analyst consensus remains Buy, with 20 analysts covered and an average 12-month price target of EUR 45.52, versus the Xetra price of EUR 37.86. The target lies 20.24 percent above the price, while the highest estimate is EUR 57.40 and the lowest is EUR 36.00, according to Investing.com. Jefferies maintained a Buy rating and a EUR 50.00 target on September 4, 2026, while Berenberg retained Neutral with a EUR 40.00 target, according to MarketScreener and MarketScreener.

Stock stays below its yearly high

Siemens Healthineers stock was last at EUR 37.86 on October 2, 2026, with a 52-week range of EUR 32.81 to EUR 49.71. Trading volume was 689,705 shares and market capitalization was EUR 42.4 billion on the same date.